Who owns RAPPORT THERAPEUTICS INC?
- CUSIP Number: 75383l102
Tip: Access positions for across all investors
Analyze quarterly positions in Rapport Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Rapport Therapeutics stock
Who bought or sold RAPPORT THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Arch Venture Corp | 3.7M | $87M | 100% | Jun 2024 |
|
| Cormorant Asset Management | 2.9M | $68M | 100% | Jun 2024 |
|
| Johnson & Johnson | 2.5M | $58M | 100% | Jun 2024 |
|
| Sofinnova Ventures | 2.0M | $45M | 100% | Jun 2024 |
|
| T. Rowe Price Investment Management | 1.5M | $36M | 100% | Jun 2024 |
|
| T. Rowe Price Associates | 1.4M | $32M | 100% | Jun 2024 |
|
| Alliancebernstein | 1.1M | $25M | 100% | Jun 2024 |
|
| Perceptive Advisors | 748k | $17M | 100% | Jun 2024 |
|
| Citadel Advisors | 593k | $13M | 100% | Jun 2024 |
|
| Artal Group | 350k | $8.1M | 100% | Jun 2024 |
|
| Logos Global Management | 209k | $4.4M | 100% | Jun 2024 |
|
| Woodline Partners | 171k | $4.0M | 100% | Jun 2024 |
|
| Millennium Management | 117k | $2.7M | 100% | Jun 2024 |
|
| TD Asset Management | 102k | $2.4M | 100% | Jun 2024 |
|
| Manufacturers Life Insurance Company | 76k | $1.8M | 100% | Jun 2024 |
|
| Vanguard Group | 70k | $1.6M | 100% | Jun 2024 |
|
| Saturn V Capital Management | 70k | $1.6M | 100% | Jun 2024 |
|
| Eventide Asset Management | 50k | $1.2M | 100% | Jun 2024 |
|
| LMR Partners | 50k | $1.2M | 100% | Jun 2024 |
|
| Monashee Investment Management | 40k | $930k | 100% | Jun 2024 |
|
| Alyeska Investment Group | 35k | $808k | 100% | Jun 2024 |
|
| Soros Fund Management | 30k | $698k | 100% | Jun 2024 |
|
| Squarepoint Ops | 16k | $380k | 100% | Jun 2024 |
|
| Two Sigma Investments | 13k | $302k | 100% | Jun 2024 |
|
| Davidson Kempner Capital Management | 10k | $229k | 100% | Jun 2024 |
|
| Balyasny Asset Management | 10k | $233k | 100% | Jun 2024 |
|
| Barclays | 9.4k | $219k | 100% | Jun 2024 |
|
| Sandia Investment Management | 5.0k | $116k | 100% | Jun 2024 |
|
| Tidemark | 1.1k | $25k | 100% | Jun 2024 |
|
| Royal Bank of Canada | 225.00 | $5.0k | 100% | Jun 2024 |
|